Concepedia

Early 18F-FDG-PET Response During Radiation Therapy for HPV-Related Oropharyngeal Cancer May Predict Disease Recurrence

Yvonne M. Mowery, Irina Vergalasova, Christel Rushing, Kingshuk Roy Choudhury, Donna Niedzwiecki, Qiuwen Wu, David S. Yoo, Shiva K. Das, Terence Z. Wong, David M. Brizel

International Journal of Radiation Oncology*Biology*Physics · 2020 · 36 citations · 34 references

DOI

Concepts

References

34

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text

, , +9

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Anil K. Chaturvedi, Eric A. Engels, Ruth M. Pfeiffer et al. · Journal of Clinical Oncology · 2011 · 3.6K citations · Full text

, , +11

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.3K citations

, , +6

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.

Ryūko Kubota, Satoshi Yamada, Keiichi Kubota et al. · PubMed · 1992 · 1.2K citations · Full text

, , +13

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 1K citations · Full text

, , +12